
### [NCIT:C7164](http://purl.obolibrary.org/obo/NCIT_C7164)
**Label:** Classical Hodgkin Lymphoma

**Subclasses:** [NCIT:C8839](http://purl.obolibrary.org/obo/NCIT_C8839) (Stage I Nodular Sclerosis Classical Hodgkin Lymphoma), [NCIT:C6913](http://purl.obolibrary.org/obo/NCIT_C6913) (Lymphocyte-Rich Classical Hodgkin Lymphoma), [NCIT:C8834](http://purl.obolibrary.org/obo/NCIT_C8834) (Stage I Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C136971](http://purl.obolibrary.org/obo/NCIT_C136971) (Recurrent Lymphocyte-Rich Classical Hodgkin Lymphoma), [NCIT:C8835](http://purl.obolibrary.org/obo/NCIT_C8835) (Stage IV Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8832](http://purl.obolibrary.org/obo/NCIT_C8832) (Recurrent Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8833](http://purl.obolibrary.org/obo/NCIT_C8833) (Refractory Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C9127](http://purl.obolibrary.org/obo/NCIT_C9127) (Adult Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C7223](http://purl.obolibrary.org/obo/NCIT_C7223) (Adult Lymphocyte-Rich Classical Hodgkin Lymphoma), [NCIT:C5067](http://purl.obolibrary.org/obo/NCIT_C5067) (Stage II Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C9125](http://purl.obolibrary.org/obo/NCIT_C9125) (Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C8650](http://purl.obolibrary.org/obo/NCIT_C8650) (Refractory Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C8651](http://purl.obolibrary.org/obo/NCIT_C8651) (Stage IV Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C3583](http://purl.obolibrary.org/obo/NCIT_C3583) (Stage III Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C5064](http://purl.obolibrary.org/obo/NCIT_C5064) (Stage I Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C3582](http://purl.obolibrary.org/obo/NCIT_C3582) (Stage III Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8063](http://purl.obolibrary.org/obo/NCIT_C8063) (Childhood Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8061](http://purl.obolibrary.org/obo/NCIT_C8061) (Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C69142](http://purl.obolibrary.org/obo/NCIT_C69142) (Childhood Classical Hodgkin Lymphoma), [NCIT:C8649](http://purl.obolibrary.org/obo/NCIT_C8649) (Recurrent Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C5077](http://purl.obolibrary.org/obo/NCIT_C5077) (Stage II Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C7054](http://purl.obolibrary.org/obo/NCIT_C7054) (Childhood Lymphocyte-Rich Classical Hodgkin Lymphoma), [NCIT:C133592](http://purl.obolibrary.org/obo/NCIT_C133592) (Recurrent Classical Hodgkin Lymphoma), [NCIT:C5081](http://purl.obolibrary.org/obo/NCIT_C5081) (Stage II Nodular Sclerosis Classical Hodgkin Lymphoma), [NCIT:C9283](http://purl.obolibrary.org/obo/NCIT_C9283) (Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C69138](http://purl.obolibrary.org/obo/NCIT_C69138) (Adult Classical Hodgkin Lymphoma), [NCIT:C27807](http://purl.obolibrary.org/obo/NCIT_C27807) (Nodular Sclerosis Classical Hodgkin Lymphoma, Syncytial Variant), [NCIT:C133736](http://purl.obolibrary.org/obo/NCIT_C133736) (Refractory Classical Hodgkin Lymphoma), [NCIT:C3518](http://purl.obolibrary.org/obo/NCIT_C3518) (Nodular Sclerosis Classical Hodgkin Lymphoma), [NCIT:C3517](http://purl.obolibrary.org/obo/NCIT_C3517) (Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C67171](http://purl.obolibrary.org/obo/NCIT_C67171) (Nodular Sclerosis Classical Hodgkin Lymphoma, Cellular Phase), 

**Class expressions from DL-Learner:**

- Thing 54.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40198](http://purl.obolibrary.org/obo/NCIT_C40198) (Cervical Squamous Intraepithelial Neoplasia 2))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40194](http://purl.obolibrary.org/obo/NCIT_C40194) (Cervical Squamotransitional Carcinoma))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40193](http://purl.obolibrary.org/obo/NCIT_C40193) (Cervical Lymphoepithelioma-Like Carcinoma))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40191](http://purl.obolibrary.org/obo/NCIT_C40191) (Cervical Warty Carcinoma))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40190](http://purl.obolibrary.org/obo/NCIT_C40190) (Cervical Verrucous Carcinoma))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4019](http://purl.obolibrary.org/obo/NCIT_C4019) (Paget Disease and Intraductal Carcinoma of the Breast))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40189](http://purl.obolibrary.org/obo/NCIT_C40189) (Cervical Basaloid Carcinoma))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40187](http://purl.obolibrary.org/obo/NCIT_C40187) (Cervical Keratinizing Squamous Cell Carcinoma))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40182](http://purl.obolibrary.org/obo/NCIT_C40182) (Uterine Corpus Carcinofibroma))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40177](http://purl.obolibrary.org/obo/NCIT_C40177) (Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40175](http://purl.obolibrary.org/obo/NCIT_C40175) (Uterine Corpus Myxoid Leiomyosarcoma))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40170](http://purl.obolibrary.org/obo/NCIT_C40170) (Uterine Corpus Diffuse Leiomyomatosis))) 36.83%


